These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11644112)

  • 1. Guidelines for genetic testing in industry.
    American Public Health Association
    Am J Public Health; 1984 Mar; 74(3):281-2. PubMed ID: 11644112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compensation for and prevention of occupational disease.
    American Public Health Association
    Am J Public Health; 1984 Mar; 74(3):292-5. PubMed ID: 11644114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational genetic testing raises major public health issues.
    Uzych L
    Med World News; 1984 Jan; 25(1):100. PubMed ID: 11645761
    [No Abstract]   [Full Text] [Related]  

  • 4. Getting beyond discrimination: a regulatory solution to the problem of fetal hazards in the workplace.
    Buss E
    Yale Law J; 1986 Jan; 95(3):577-98. PubMed ID: 11658700
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic tests: can we afford the answers?
    Zoler ML
    Med World News; 1991 Jan; 32(1):32-7. PubMed ID: 11653931
    [No Abstract]   [Full Text] [Related]  

  • 6. Increasing worker and community awareness of toxic hazards in the workplace.
    American Public Health Association
    Am J Public Health; 1985 Mar; 75(3):305-8. PubMed ID: 11643733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of for-profit health care institutions.
    American Public Health Association
    Am J Public Health; 1984 Mar; 74(3):286-7. PubMed ID: 11644113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV guidelines for the workplace.
    American Public Health Association
    Am J Public Health; 1990 Feb; 80(2):241-2. PubMed ID: 11642751
    [No Abstract]   [Full Text] [Related]  

  • 9. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic secrets: social issues of medical screening in a genetic age.
    Draper E
    Hastings Cent Rep; 1992; 22(4 Suppl):S15-8. PubMed ID: 11652052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal protection programs under Title VII--rebutting the procreation assumption.
    Blanco AC
    Univ Pittsbg Law Rev; 1985; 46(3):755-94. PubMed ID: 11649206
    [No Abstract]   [Full Text] [Related]  

  • 12. Worker notification and institutional review for privately funded research in occupational health and safety.
    American Public Health Association
    Am J Public Health; 1996 Mar; 86(3):432-3. PubMed ID: 11644772
    [No Abstract]   [Full Text] [Related]  

  • 13. Medical genetics: present and future benefits.
    Elsas LJ
    Emory Law J; 2000; 49(3):801-22. PubMed ID: 12645563
    [No Abstract]   [Full Text] [Related]  

  • 14. The total gene screen.
    Hunt M
    N Y Times Mag; 1986 Jan; ():33, 38, 50, 52+. PubMed ID: 11646178
    [No Abstract]   [Full Text] [Related]  

  • 15. The corporate practice of medicine doctrine: an anachronism in the modern health care industry.
    Chase-Lubitz JF
    Vanderbilt Law Rev; 1987 Mar; 40(2):445-88. PubMed ID: 11649888
    [No Abstract]   [Full Text] [Related]  

  • 16. Which ills to bear?: reevaluating the "threat" of modern genetics.
    Capron AM
    Emory Law J; 1990; 39(3):665-96. PubMed ID: 11653905
    [No Abstract]   [Full Text] [Related]  

  • 17. Biological monitoring: the employer's dilemma.
    Miller FH
    Am J Law Med; 1984; 9(4):388-426. PubMed ID: 11644166
    [No Abstract]   [Full Text] [Related]  

  • 18. Creating a genetic underclass: the potential for genetic discrimination by the health insurance industry.
    Lee C
    Pace Law Rev; 1993; 13(1):189-228. PubMed ID: 11659744
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic testing in insurance underwriting: a blessing or a curse? An examination of the tension between economics and equity in using genetic testing in risk classification.
    Anderson MC
    Creighton Law Rev; 1992 Jun; 25(4):1499-535. PubMed ID: 11654461
    [No Abstract]   [Full Text] [Related]  

  • 20. Public policy and legal issues raised by advances in genetic screening and testing.
    Reilly PR
    Suffolk Univ Law Rev; 1993; 27(4):1327-57. PubMed ID: 11657041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.